Abstract
In principle, two research approaches can be considered for the
laboratory diagnosis of transmissible spongiform encephalopathies (TSE): (i)
the direct detection of PrP
It was shown that a single determination of just a few markers (tau-protein, S-100B, 14-3-3-protein) was already sufficient to achieve a high degree of diagnostic certainty in the diagnosis of CJD. On the basis of the available data, it is to be expected that a combination of these markers will bring improved diagnostic strength with regard to the differential diagnosis of dementias as a whole. This especially applies to some of the subtypes of CJD and Alzheimer's dementia (AD).
Get full access to this article
View all access options for this article.
